Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Montserrat Domenech Santasusana"'
Autor:
Guillermo de Velasco, Teresa Alonso-Gordoa, Alejo Rodríguez-Vida, Georgia Anguera, Marc Campayo, Álvaro Pinto, Esther Martínez Ortega, Enrique Gallardo, Natalia Fernández Núñez, Iciar García-Carbonero, Oscar Reig, María José Méndez-Vidal, Ovidio Fernández-Calvo, Natalia Vidal Cassinello, Dolores Torregrosa, Ana López-Martín, Adriana Rosero, Patricia G. Valiente, Carmen Garcías de España, Miguel A. Climent, Montserrat Domenech Santasusana, Ángel Rodríguez Sánchez, Isabel Chirivella González, Ruth Afonso, Xavier García del Muro, Javier Casinello, Eva M. Fernández-Parra, Lourdes García Sánchez, Javier Afonso, Susana Hernando Polo, Úrsula Asensio
Publikováno v:
Clinical Genitourinary Cancer. 21:e166-e174
The long-term clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) and a complete response (CR) to the tyrosine kinase inhibitor (TKI) sunitinib are poorly known. The characteristics of these patients could reveal previously unde
Autor:
Elisabet Sunyer Miralda, Ariadna Gómez Velasco, Griselda Sirvent Batalla, Maria Neus Ticó Falguera, Irene Alonso Estany, Montserrat Domenech Santasusana
Publikováno v:
Scientific Medical Data.
Autor:
Oscar Reig Torras, Natalia Jiménez, Marta Garcia de Herreros, Caterina Aversa, Mercedes Marin, Laura Ferrer, Leonardo Rodriguez-Carunchio, Isabel Trias, Laia Fernandez-Mañas, Samuel García-Esteve, Albert Font Pous, Alejo Rodriguez-Vida, Montserrat Domenech-Santasusana, Mariona Figols, Miguel Ángel Climent, Sara Cros Costa, Isabel Chirivella, Daniel Herrero Rivera, Cristina Suárez, Begoña Mellado-Gonzalez
Publikováno v:
Journal of Clinical Oncology. 41:236-236
236 Background: Alterations on the tumor suppressor genes (TSG) RB1, PTEN and TP53 are associated with treatment resistance and aggressive clinical evolution of prostate cancer patients (pts). We developed and assessed the role of a TSG gene expressi
Autor:
Caterina Aversa, Natalia Jiménez, Mercedes Marin, Laura Ferrer-Mileo, Oscar Reig, Leonardo Rodriguez-Carunchio, Albert Font, Alejo Rodriguez-Vida, Montserrat Domenech-Santasusana, Mariona Figols, Miguel Angel Climent Duran, Sara Cros Costa, Isabel Chirivella, Daniel Herrero Rivera, Enrique Gonzalez -Billalabeitia, Daniel Jiménez-Peralta, Joan Carles, Cristina Suárez, Aleix Prat, Begona Mellado
Publikováno v:
Journal of Clinical Oncology. 40:5077-5077
5077 Background: TMPRSS2-ERG fusion has been associated with estrogen receptor (ER) signalling in prostate cancer (PC). The isoform beta of ER (ERβ), encoded by ESR2, is considered anti-proliferative and tumor-suppressive. In preclinical studies, ES
Autor:
Sergio Vazquez-Estevez, Ovidio Fernandez-Calvo, Teresa Bonfill-Abella, Silvia Sequero, Francisca Martínez-Madueño, Nuria Romero-Laorden, Montserrat Domenech-Santasusana, Elena Sevillano, José García Sánchez, Carlos Alvarez-Fernandez, Cristina Núñez-González
Publikováno v:
Journal of Clinical Oncology. 40:4588-4588
4588 Background: Combined-modality treatments are bladder-preserving alternatives for patients (pts) who are not candidates for radical cystectomy by medical reasons, refusal, or patient´s choice. Immune therapies seem to potentiate tumor-specific i